News posted in Company News

Our latest Quarterly Journal looks at the ways in which universities can make the most of their environment.

Posted on Thursday, 13 December 2018 @ 10:28

An interview with Peter Grant, Managing Director of New Business & Partnerships at IP Group plc.


Posted on Tuesday, 20 December 2016 @ 09:00

On 13 March Certara, a US-based provider of drug discovery and development software and scientific consulting services, completed its acquisition of Simcyp, a spinout from the
University of Sheffield, for US$32 million.

Posted on Friday, 08 June 2012 @ 17:29

Our third quarterly Journal, giving news and comment on the spinouts sector, is now available for download. The Quarterly Journals are free of charge, so please forward them to any colleagues or o...

Posted on Thursday, 15 March 2012 @ 11:02

On 20 October 2011 PraxisUnico became the lead partner in Young Company Finance’s Spinouts UK project - a listing of all spinouts from UK universities since 2000, with information about their origins, their activity, their growth, and their current status.


Posted on Thursday, 24 November 2011 @ 10:27

Q Chip is developing sustained-release drug formulations for cancer and other diseases.

Posted on Monday, 01 August 2011 @ 17:32

Haemostatix announced on 28 June that it has received an investment of £250k from Esperante Ventures to support development of its innovative haemostat technology.

Posted on Monday, 01 August 2011 @ 17:27

Belfast based business development agency, Ortus announced in July the acquisition of University of Ulster spin out company, Flex Language Services.

Posted on Monday, 01 August 2011 @ 17:16

A new company set up to revolutionise semiconductors is was launched on 1 July 2011 at the University of Warwick.

Posted on Monday, 01 August 2011 @ 17:14

In May Abcodia announced the completion of a £1 million investment by Albion Ventures and UCL Business plc (UCLB).

Posted on Monday, 01 August 2011 @ 17:12

Azellon is a spin-out from The University of Bristol focused on the R&D and commercialisation of an adult autologous (patient's own) stem cell technology for the repair of avascular meniscal tears.

Posted on Tuesday, 21 June 2011 @ 17:37

Outstanding contributions to the commercialisation of university research were recognised  at the PraxisUnico Conference 2011 in Glasgow on 10 June.

Posted on Tuesday, 21 June 2011 @ 17:36

Cambridge-based Lab21, which specialises in personalised medicine and clinical diagnostics, announced in May that it had acquired Myconostica, a molecular diagnostic company focusing on the diagnosis of fungal infections of clinical importance.

Posted on Tuesday, 21 June 2011 @ 17:35

The University of Strathclyde took the strategic decision to invest in EnviroCentre as a spin-out company in 1995, and the company has gone on to become one of Scotland’s leading environmental consultancies.

Posted on Tuesday, 21 June 2011 @ 17:32

In May the company completed a seed funding round of equity investment led by Mercia Fund Management, and announced its participation in a £2.1 million project funded by the TSB, EPSRC, and industrial partners.

Posted on Tuesday, 21 June 2011 @ 17:31

The SETsquared partnership has announced that one of the companies it has supported, Fitronics, has completed a successful sale of the business.

Posted on Tuesday, 21 June 2011 @ 17:25

Biovex, a cancer vaccine developer spun out of University College London (UCL) a decade ago, was acquired in January by US biotechnology giant Amgen for $1 billion.

Posted on Friday, 11 March 2011 @ 10:36